# Filing Detail

Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001140361-22-016533
Filing Date
2022-04-28
Accepted
2022-04-28 16:15:08
Documents
4

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | DEFA14A | ny20001491x2_defa14a.htm | DEFA14A | 10654
2 |  | logo_royaltypharma.jpg | GRAPHIC | 26772
3 |  | ny20001491x2_nc1.jpg | GRAPHIC | 2051930
4 |  | ny20001491x2_nc2.jpg | GRAPHIC | 1827878
| Complete submission text file | 0001140361-22-016533.txt |  | 5094498

Mailing Address 110 EAST 59TH STREET NEW YORK NY 10022
Business Address 110 EAST 59TH STREET NEW YORK NY 10022 (212) 883-0200
Royalty Pharma plc (Filer) CIK: 0001802768 (see all company filings)

EIN.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-39329 | Film No.: 22866739
SIC: 2834 Pharmaceutical Preparations